The FDA is working on a plan to allow pharmaceutical companies to distribute information to doctors about a drug’s off label usage. The information would be stricly monitored and would include articles from scholarly medical journals. However, if the findings from the medical journal are disputed, the contrary evidence would have to be included in the dissemination to doctors. Off label prescribing of drugs is common and is not illegal, drug companies are prohibited from marketing drugs for purposes that are not specifically approved by the FDA.
For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.